January 9, 2020 8:11am
News: Applied Genetic Technologies Corporation (AGTC) reported positive interim six-month data from its ongoing P1/2 clinical program in X-linked retinitis pigmentosa (XLRP). AGTC is UP +$2.63 or +63.22% in the pre-market.
Pre-open indications: flashing a warning, you’d be aware if a subscriber
My version of the morning’s numbers is written to be informative; it’s includes what happened or will beyond the headline and shapes today’s markets as seen by RMi - SUBSCRIBE
Members only. Please login.